Gland Pharma

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,844.25",
    "chg": -5.55,
    "chgp": "-0.3%",
    "dir": -1,
    "prev_price": "1,849.80",
    "mcapval": "30,200.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE068V01023",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "45.93 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Gains 0.35%: 3 Key Technical and Financial Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-035-3-key-technical-and-financial-factors-driving-the-week-3825964",
        "imagepath": "",
        "date": "2026-02-07 11:05:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> MarketsMOJO upgrades Gland Pharma to Hold following strong quarterly results</p>\n                    <p><strong>3 Feb:</strong> Mixed technical signals emerge amid sideways price momentum</p>\n                    <p><strong>4 Feb:</strong> Technical momentum shifts to mildly bullish despite minor price dip</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.1,852.05, up 0.35% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,845.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">..."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3819833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GlandPharmaLtd_technicaldot_3819833.png",
        "date": "2026-02-04 08:07:12",
        "description": "Gland Pharma Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautiously optimistic outlook for the pharmaceutical and biotechnology company amid broader market dynamics."
      },
      {
        "title": "Gland Pharma Ltd Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-3817404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GlandPharmaLtd_mojoScore_3817404.png",
        "date": "2026-02-03 08:23:07",
        "description": "Gland Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, technical indicators, and valuation metrics. The pharmaceutical company’s recent quarterly results and market behaviour have prompted analysts to revise their outlook, signalling cautious optimism amid a very expensive valuation backdrop."
      },
      {
        "title": "Gland Pharma Ltd Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-3817284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GlandPharmaLtd_technicaldot_3817284.png",
        "date": "2026-02-03 08:04:58",
        "description": "Gland Pharma Ltd has exhibited a notable shift in its technical parameters, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of momentum indicators. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests a cautious outlook for investors amid ongoing volatility in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Gains 9.73%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-973-5-key-factors-driving-the-weeks-rally-3812726",
        "imagepath": "",
        "date": "2026-01-31 12:00:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock opens week at Rs.1,675.35, down 0.39% despite Sensex rise</p>\n                    <p><strong>28 Jan:</strong> Q3 FY26 results reveal record revenue and profit</p>\n                    <p><strong>29 Jan:</strong> Significant gap-up and intraday high of Rs.1,849 with 7.6% surge</p>\n                    <p><strong>30 Jan:</strong> Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,845.60</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,681.95</div></div>\n                    <div class=\"stat-item\"><div class=\"s..."
      },
      {
        "title": "Gland Pharma Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3810678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_technicaldot_3810678.png",
        "date": "2026-01-30 08:02:47",
        "description": "Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex array of technical indicators that suggest a transition from bearish to mildly bearish trends. Despite a robust day change of 6.75%, the stock’s technical parameters present a nuanced picture, with some indicators signalling caution while others hint at potential recovery. This article analyses the latest technical data, placing Gland Pharma’s performance in the context of broader market movements and sectoral trends."
      },
      {
        "title": "Are Gland Pharma Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gland-pharma-ltd-latest-results-good-or-bad-3810125",
        "imagepath": "",
        "date": "2026-01-29 19:25:24",
        "description": "Gland Pharma Ltd's latest financial results for Q3 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹279.06 crores, reflecting a year-on-year growth of 36.30%, while revenue reached ₹1,695.36 crores, marking a 22.49% increase compared to the same quarter last year. This revenue figure represents a sequential growth of 14.02% from the previous quarter, indicating strong demand, particularly in its injectable portfolio and key export markets like the United States.\n\nHowever, the operating margin has come under pressure, decreasing to 19.07%, down 201 basis points year-on-year. This decline is attributed to rising employee costs and increased manufacturing expenses as Gland Pharma scales its production capacity. Despite the growth in revenue and net profit margins, which improved to 16.46% from 14.79% in the prior year, the reliance on exceptional other income, whi..."
      },
      {
        "title": "Gland Pharma Ltd Hits Intraday High with 7.6% Surge on 29 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-hits-intraday-high-with-76-surge-on-29-jan-2026-3808981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_priceRelatedfactors_3808981.png",
        "date": "2026-01-29 09:32:58",
        "description": "Gland Pharma Ltd recorded a robust intraday performance on 29 Jan 2026, surging to an intraday high of Rs 1849, marking a 9.49% rise from its previous close. The stock outperformed its sector and broader market indices, reflecting significant trading momentum and volatility throughout the session."
      },
      {
        "title": "Gland Pharma Ltd Opens Strong with Significant Gap Up on 29 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-opens-strong-with-significant-gap-up-on-29-jan-2026-3808967",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GlandPharmaLtd_gapup_3808967.png",
        "date": "2026-01-29 09:31:33",
        "description": "Gland Pharma Ltd commenced trading on 29 Jan 2026 with a significant gap up, opening 7.72% higher than its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company amid a backdrop of notable outperformance relative to its sector and benchmark indices."
      }
    ],
    "total": 336,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Feb-2026",
      "details": "Gland Pharma receives approval for Zoledronic Acid Injection 4 mg/ 100 mL (0.04 mg/mL) Single-Dose Bags",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Feb-2026",
      "details": "Q3FY26 Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "01-Feb-2026",
      "details": "Schedule of Investors Meet",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gland Pharma Gains 0.35%: 3 Key Technical and Financial Factors Driving the Week

2026-02-07 11:05:10

Key Events This Week

2 Feb: MarketsMOJO upgrades Gland Pharma to Hold following strong quarterly results

3 Feb: Mixed technical signals emerge amid sideways price momentum

4 Feb: Technical momentum shifts to mildly bullish despite minor price dip

6 Feb: Week closes at Rs.1,852.05, up 0.35% for the week

Week Open

Rs.1,845.60

...

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-02-04 08:07:12

Gland Pharma Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautiously optimistic outlook for the pharmaceutical and biotechnology company amid broader market dynamics.

Read full news article

Gland Pharma Ltd Upgraded to Hold as Financial and Technical Trends Improve

2026-02-03 08:23:07

Gland Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, technical indicators, and valuation metrics. The pharmaceutical company’s recent quarterly results and market behaviour have prompted analysts to revise their outlook, signalling cautious optimism amid a very expensive valuation backdrop.

Read full news article

Gland Pharma Ltd Shows Mixed Technical Signals Amid Price Momentum Shift

2026-02-03 08:04:58

Gland Pharma Ltd has exhibited a notable shift in its technical parameters, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of momentum indicators. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests a cautious outlook for investors amid ongoing volatility in the Pharmaceuticals & Biotechnology sector.

Read full news article

Gland Pharma Gains 9.73%: 5 Key Factors Driving the Week’s Rally

2026-01-31 12:00:12

Key Events This Week

27 Jan: Stock opens week at Rs.1,675.35, down 0.39% despite Sensex rise

28 Jan: Q3 FY26 results reveal record revenue and profit

29 Jan: Significant gap-up and intraday high of Rs.1,849 with 7.6% surge

30 Jan: Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,845.60

Week Open

Rs.1,681.95

Read full news article

Gland Pharma Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-30 08:02:47

Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex array of technical indicators that suggest a transition from bearish to mildly bearish trends. Despite a robust day change of 6.75%, the stock’s technical parameters present a nuanced picture, with some indicators signalling caution while others hint at potential recovery. This article analyses the latest technical data, placing Gland Pharma’s performance in the context of broader market movements and sectoral trends.

Read full news article

Are Gland Pharma Ltd latest results good or bad?

2026-01-29 19:25:24

Gland Pharma Ltd's latest financial results for Q3 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹279.06 crores, reflecting a year-on-year growth of 36.30%, while revenue reached ₹1,695.36 crores, marking a 22.49% increase compared to the same quarter last year. This revenue figure represents a sequential growth of 14.02% from the previous quarter, indicating strong demand, particularly in its injectable portfolio and key export markets like the United States. However, the operating margin has come under pressure, decreasing to 19.07%, down 201 basis points year-on-year. This decline is attributed to rising employee costs and increased manufacturing expenses as Gland Pharma scales its production capacity. Despite the growth in revenue and net profit margins, which improved to 16.46% from 14.79% in the prior year, the reliance on exceptional other income, whi...

Read full news article

Gland Pharma Ltd Hits Intraday High with 7.6% Surge on 29 Jan 2026

2026-01-29 09:32:58

Gland Pharma Ltd recorded a robust intraday performance on 29 Jan 2026, surging to an intraday high of Rs 1849, marking a 9.49% rise from its previous close. The stock outperformed its sector and broader market indices, reflecting significant trading momentum and volatility throughout the session.

Read full news article

Gland Pharma Ltd Opens Strong with Significant Gap Up on 29 Jan 2026

2026-01-29 09:31:33

Gland Pharma Ltd commenced trading on 29 Jan 2026 with a significant gap up, opening 7.72% higher than its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company amid a backdrop of notable outperformance relative to its sector and benchmark indices.

Read full news article

View All News